Rotech reports $2.9 million loss
ORLANDO, Fla. - Rotech's net revenues inched up to $132.5 million for the first quarter of this year compared to $123.3 million for the same quarter last year. The company also reported a net loss of $2.9 million for the first quarter this year compared to a loss of $3 million for the same quarter last year. Like other national providers, Rotech's financial earnings took a hit due to Medicare reimbursement reductions for respiratory medications, especially reimbursement for compounded budesonide. In all, the reimbursement reductions for respiratory medications delivered a $11.25 million blow to recorded revenues.